Key result
A combination of cardiac magnetic resonance imaging parameters (edema ratio and global relative enhancement) detected sub-clinical acute cellular rejection with a sensitivity of 84% and a negative predictive value of 96% compared to endomyocardial biopsy.
Why the study?
Does multi-sequential cardiac magnetic resonance imaging accurately detect sub-clinical acute cellular rejection compared to endomyocardial biopsy in heart transplant recipients?
Cross-Sectional (n=73)
No
Does multi-sequential cardiac magnetic resonance imaging accurately detect sub-clinical acute cellular rejection compared to endomyocardial biopsy in heart transplant recipients?
Multi-sequential CMR has a high negative predictive value for excluding acute cellular rejection after heart transplantation, but its low positive predictive value means it cannot yet replace endomyocardial biopsy.
Answers are grounded in this paper and cite their sources.
CMR's high NPV may aid noninvasive exclusion of sub-clinical rejection; leaves open whether it can safely reduce EMB frequency.
OBJECTIVE: Comparing the diagnostic value of multi-sequential cardiac magnetic resonance imaging (CMR) with endomyocardial biopsy (EMB) for sub-clinical cardiac allograft rejection. METHODS: One hundred and forty-six examinations in 73 patients (mean age 53 ± 12 years, 58 men) were performed using a 1.5 Tesla system and compared to EMB. Examinations included a STIR (short tau inversion recovery) sequence for calculation of edema ratio (ER), a T1-weighted spin-echo sequence for assessment of global relative enhancement (gRE), and inversion-recovery sequences to visualize late gadolinium enhancement (LGE). Histological grade ≥1B was considered relevant rejection. RESULTS: One hundred and twenty-seven (127/146 = 87 %) EMBs demonstrated no or mild signs of rejection (grades ≤1A) and 19/146 (13 %) a relevant rejection (grade ≥1B). Sensitivity, specificity, positive predictive, and negative predictive values were as follows: ER: 63 %, 78 %, 30 %, and 93 %; gRE: 63 %, 70 %, 24 %, and 93 %; LGE: 68 %, 36 %, 13 %, and 87 %; with the combination of ER and gRE with at least one out of two positive: 84 %, 57 %, 23 %, and 96 %. ROC analysis revealed an area under the curve of 0.724 for ER and 0.659 for gRE. CONCLUSION: CMR parameters for myocarditis are useful to detect sub-clinical acute cellular rejection after heart transplantation. Comparable results to myocarditis can be achieved with a combination of parameters. KEY POINTS: • Magnetic resonance imaging is useful for the assessment of cardiac allograft rejection. • CMR has a high negative predictive value for exclusion of allograft rejection. • Diagnostic performance is not yet good enough to replace endomyocardial biopsy.
No takes yet. Share an insight, caveat, or question.
Krieghoff et al. (2014) conducted a cross-sectional in Sub-clinical acute cellular rejection after heart transplantation (n=73). Multi-sequential cardiac magnetic resonance imaging (CMR) vs. Endomyocardial biopsy (EMB) was evaluated on Diagnostic accuracy (sensitivity, specificity, NPV) for relevant acute cellular rejection (histological grade ≥1B) using a combination of edema ratio (ER) and global relative enhancement (gRE) (Sensitivity 84%, Specificity 57%, NPV 96%). A combination of cardiac magnetic resonance imaging parameters (edema ratio and global relative enhancement) detected sub-clinical acute cellular rejection with a sensitivity of 84% and a negative predictive value of 96% compared to endomyocardial biopsy.
Synapse has enriched 10 related papers. Consider them for comparative context: